News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
830,080 Results
Type
Article (85544)
Company Profile (744)
Press Release (743792)
Section
Business (232227)
Career Advice (4102)
Deals (39640)
Drug Delivery (114)
Drug Development (90622)
Employer Resources (194)
FDA (17974)
Job Trends (17268)
News (395520)
Policy (39615)
Tag
Academia (2975)
Alliances (56413)
Alzheimer's disease (1326)
Approvals (17870)
Artificial intelligence (146)
Bankruptcy (394)
Best Places to Work (12475)
Biotechnology (507)
Breast cancer (122)
Cancer (1056)
Career advice (3510)
Cell therapy (243)
Clinical research (71287)
Collaboration (369)
Compensation (180)
COVID-19 (2796)
C-suite (95)
Data (969)
Diabetes (156)
Diagnostics (6655)
Drug pricing (101)
Earnings (94421)
Employer resources (167)
Events (126421)
Executive appointments (271)
FDA (18463)
Funding (324)
Gene therapy (177)
GLP-1 (685)
Government (5043)
Healthcare (20706)
Infectious disease (2884)
Inflammatory bowel disease (115)
Interviews (807)
IPO (17570)
Job creations (5178)
Job search strategy (2853)
Layoffs (485)
Legal (10039)
Lung cancer (176)
Manufacturing (184)
Medical device (14390)
Medtech (14395)
Mergers & acquisitions (22079)
Metabolic disorders (444)
Neuroscience (1600)
NextGen Class of 2024 (7656)
Non-profit (5063)
Northern California (1343)
Obesity (261)
Opinion (241)
Patents (105)
People (64064)
Pharmaceutical (147)
Phase I (21931)
Phase II (30945)
Phase III (23351)
Pipeline (327)
Postmarket research (3539)
Preclinical (9917)
Radiopharmaceuticals (256)
Rare diseases (214)
Real estate (7371)
Regulatory (25897)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1206)
Startups (4274)
United States (13421)
Vaccines (645)
Weight loss (215)
Date
Last 7 days (1140)
Last 30 days (3430)
Last 365 days (38216)
2024 (33748)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (224)
Asia (49267)
Australia (8678)
California (3145)
Canada (1227)
China (236)
Colorado (138)
Connecticut (150)
Europe (112806)
Florida (429)
Georgia (115)
Illinois (397)
Indiana (207)
Kansas (103)
Maryland (596)
Massachusetts (2620)
Michigan (165)
Minnesota (282)
New Jersey (920)
New York (918)
North Carolina (813)
Northern California (1343)
Ohio (139)
Pennsylvania (805)
South America (1647)
Southern California (1206)
Texas (449)
Washington State (376)
There are 830,080 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
November 8, 2024
·
18 min read
Press Releases
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
November 8, 2024
·
6 min read
Press Releases
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma
November 8, 2024
·
11 min read
Press Releases
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
November 8, 2024
·
3 min read
Press Releases
Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 8, 2024
·
9 min read
Press Releases
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
November 8, 2024
·
16 min read
Press Releases
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
November 8, 2024
·
9 min read
Press Releases
CareRx Reports Results for the Third Quarter of 2024
November 8, 2024
·
10 min read
Press Releases
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma
November 8, 2024
·
22 min read
Press Releases
Medigene Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024
November 8, 2024
·
5 min read
1 of 83,008
Next
